Clinical studies of the interaction of hexafluorenium and succinylcholine in man.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000768:Anesthesia, General; D004357:Drug Synergism; D005260:Female; D006221:Halothane; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009125:Muscle Relaxants, Central / Q000494:pharmacology; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D013390:Succinylcholine / Q000008:administration & dosage / Q000494:pharmacology*; D013997:Time Factors
D009125:Muscle Relaxants, Central; D003473:Neuromuscular Nondepolarizing Agents; D000644:Quaternary Ammonium Compounds; D013390:Succinylcholine; D006221:Halothane